PHR
Phreesia, Inc.16.35
-0.35-2.1%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '26
Key Stats
Market Cap
985.69MP/E (TTM)
-Basic EPS (TTM)
-0.09Dividend Yield
0%Recent Filings
8-K
Kessler joins Phreesia board
Phreesia announced on February 23, 2026, that directors Edward L. Cahill and Chair Michael Weintraub will retire at the 2026 annual meeting, with no disagreements cited. The board appointed Jon Kessler, ex-CEO of HealthEquity and WageWorks, effective April 6, 2026, granting him RSUs valued at $40,041 prorated and $185,000 new-hire. Board expands temporarily to nine, then shrinks to seven independents. Kessler adds healthcare tech scaling expertise.
10-Q
Q3 FY2026 results
Phreesia posted Q3 FY2026 revenue of $120.3M, up 13% y/y from $106.8M, with subscription services at $55.5M (+12%), payments $27.4M (+11%), and network solutions $37.4M (+14%); operating income flipped to $3.7M from a $13.8M loss. Diluted EPS hit $0.07 on 61.6M shares, matching net income of $4.3M. Cash from operations jumped to $15.5M, funding $8.8M free cash flow (operating cash minus capex); cash ended at $106.4M. Post-quarter, closed AccessOne acquisition in November 2025 for ~$160M cash (funded by $110M Bridge Loan at SOFR+4%, due Nov 2026). Solid margins emerged. Yet competition from EHRs looms.
8-K
Q3 beat, AccessOne closed
Phreesia posted Q3 revenue of $120.3M, up 13% YoY, with net income of $4.3M versus prior loss and Adjusted EBITDA tripling to $29.1M. Closed AccessOne acquisition November 12 for ~$160M cash, funded partly by $110M bridge loan, to bolster healthcare financing. Raised FY26 outlook to $479-481M revenue, $99-101M Adjusted EBITDA; debuted FY27 at $545-559M revenue. Integration risks loom.
8-K
Phreesia closes AccessOne deal
10-Q
Q2 FY2026 results
Phreesia swung to a $0.7M net profit in Q2 FY2026 ended July 31, 2025, from a $18.0M loss a year earlier, as total revenue climbed 15% y/y to $117.3M on 10% subscription growth to $53.7M, 12% payment fees to $28.4M, and 25% network solutions to $35.2M; operating loss narrowed to $1.5M from $17.2M, with gross margin steady at 85.2% (derived). YTD revenue rose 15% to $233.2M, but net loss widened slightly to $3.3M from $3.7M, reconciling to Q1's $3.9M loss; diluted EPS of $0.01 matched basic on 61.7M shares, with no anti-dilution flagged. Cash hit $98.3M, up from $84.2M at FYE, with $29.7M YTD operating cash flow and $17.1M free cash flow (derived as operating cash minus $12.6M capex); total debt fell to $11.7M from $16.2M, supported by a $50M undrawn Capital One revolver at 7.4% with covenant compliance. Post-quarter, Phreesia agreed to acquire AccessOne for $160M cash in Q3/Q4 FY2026, funded by cash and bridge debt, to bolster patient financing. Yet competition from EHR systems remains a key risk.
IPO
Website
Employees
Sector
Industry
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
DH
Definitive Healthcare Corp.
2.29-0.01
FORA
Forian Inc.
2.14+0.00
HSTM
HealthStream, Inc.
23.91-0.47
HYDTF
Hydreight Technologies Inc
3.10-0.06
PAXH
PreAxia Health Care Payment Sys
0.22+0.00
PRVA
Privia Health Group, Inc.
23.81-0.53
SOPH
SOPHiA GENETICS SA
4.81+0.09
TDOC
Teladoc Health, Inc.
7.41+0.07
WEAV
Weave Communications, Inc.
6.98+0.23